Bridging the Gap: Conference Workbook [International Conference on AIDS (12th: 1994: Geneva, Switzerland)]

Thursday, July 2

R S N Tc A 4

41184 Accumulation of gag-pol polyprotein intermediated in HIV-infected cells
thrated with protease inhibitors
Renae Speck*; Renae Speck; C. Flexner; X-F. Yu, USA
41185 Effects of HAART on HIV viral load and CD4 T-Cells in the mucosaassociated lymphoid tissue (MALT) and blood
Wolfgang Schmidt*; M. Schaefer; 0. Faculer; U. Bauer; N. MuellerLantsch; E.O. Riecken; R. Ullrich, Germany
41186 Anti-HIV and immunomodulatory effects of interferont, a new type I
interferon
Marc Martin*; N. Dereuddre-Bosquet; P. Clayette; P. Fretier; G. Gras;
J. Martal; D. Dormont, France
41187 Targeting anti-HIV agents to nucleocapsid protein zinc knuckles
without affecting cellular zinc finger proteins
William Rice*;J.A. Turpin; G.M. Janini; A. Maynard; D.G. Covell;
M. Huang, USA
41188 Anti-HIV-1 activity of combinations and covalent conjugates of
negatively charged albumins and AZT
Mirjam E. Kuipers*; P.J. Swart; M. Witvrouw; J.A. Este; E. De Clercq;
D.K.F. Meijer, The Netherlands
41189 The effect of triple combination in HIV-1 experienced patients
Enzo Raise*; Sandro Pasquiwucci; G. Rosini; M. Bechi; F. Cavinato;
C. Ortolani, Italy
41190 Destruction of gp41 of HIV-1 envelope by its catalytic antibody
Taizo Uda*; E. Hifumi; Y. Okamoto; Y. Zhou; M. Ishimaru, Japan
41191 Predictors of response to treatment Of HIV-1 infected children with
the protease inhibitor nelfinavir mesylate
Paul Krogstad*; A. Wiznia; K. Luzuriaga; S.A. Spector; W. Dankner;
M. Gersten; Y. Bryson, USA
41192 The entry of 1592 (abacavir) into the guinea-pig brain: Comparison
with other reverse transcriptase inhibitors
Sarah Thomas*; J.E. McDowall; V. Cheah; A. Bye; M.B. Segal
41193 Evaluation of lymphocyte functionality and activation markers
expression before and after antiretroviral in HIV-1-infected subjects.
A four years follow-up
Maurizio Carlesimo*; M.L. Bernardi; C. Alario; R. Rosso; R. Ferrara;
A. Prozzo; F. Aiuty, Italy
41194 The Five-to-NoneTrial (Essai CINQ-A-ZERO):5 antiretrovirals combined
during 6 months as first treatment course for HIV-1 infected treatmentnafve patients
Jacques Leibowitch*; D. Mathez; M. Elissalt; A. Neumann; A. Saimot,
France
41195 Adefovir (PMEA) and PMPA show synergistic or additive inhibition of
HIV replication in vitro in combination with other anti-HIV agents
Julie Cherrington*; A.S. Mulato, USA
41196 Characterization of the anti-HIV properties, resistance profile and safety
of dOTC (2'-deoxy-3'-oxa-4' thiocytidine)
Jean Bedard*; Terry Bowlin; Wainberg; Tarek Mansour; Stan Tyms;
Patricia Williams; Debra Taylor; Caroline Fortier, Canada
41197 Purification and characterization of an anti-HIV substance from Perilla
frutescens Britton, mint plant
Shuichi Oka*; Y. Fukumori; Y. Sapporo; Y. Yamazaki; T. Kawahata;

T. Otake; H. Mori; Y. Izumoto;. Oishi, Japan

41198 Development and characterization of HIV-1 resistant to modified
cyclodextrin sulfate (mCDS) 71 in vitro
Haruyo Mori*; T. Otake; T. Kawahata; Y. Izumoto; I. Oishi; T. Kurimura,
Japan
41199 Solidarity network of people with HIV/AIDS
Rodolfo Solano, Costa Rica
41200 Synthesis, chiral separation and anti-HIV activity ofenantiomeric
oxaselenolane nucleosides
David C.K. Chu*; R.F. Schinazi; L. Ma; J. Du; S. Wirtz; J. Shi; C. Pierra, USA
41201 Two- and three-protease inhibitor combinations against zidovudinesensitive and zidovudine-resistant HIV-1 isolates in vitro
Cecile Tremblay*; D.P. Merrill; T.C. Chou; M.S. Hirsch, USA
41202 Methadone and protease inhibitors in HIV-infected drug abusers
Gianpiero D'Offizi*; G. Campitelli; R. Urso; C. Carvelli; G. Cerasari;
M. Zaccarelli; P. Narciso, Italy
41203 Anti-human immunodeficiency virus type 1 activities of proteins
from 17 species of plants
Kun Long Ben*; Y.T. Zheng, P.R. China
41204 HIV-infection inhibitors: Carbohydrate-containing biopolymers (CCBs)
of bacterial and lymphoid cells Svitlana L.
Rybalko*; W. Anatoly Shapiro; T. Dyadun Svitlana; Grytsak Tanja;
V. Nesterova Nadya; S. Dyachenko Nata; Varbanets Ljuda;
N. Zherentsova Ella; Ivanskaja Naiija; M. Shcherbinskaja Alla, Ukraine
41205 Inhibition of HIV-1 replication by newly developed polymeric
adamantane analogue
Marina Boursteine*; A. V. Serbin; L.L. Stotskaya; T.V. Khakhulina;
A.G. Boukrinskaya, Russia
41206 Structure/function relationship oftrichosanthin (TCS) on anti-human
immunodeficiency virus type 1 activity
Yong Tang Zheng*; Y. T. Zheng; B.L. Ben; H.L. Nie,
The People's Republic of China
41207 Anti-human immunodeficiency virus (HIV) activity,of NARL-1,an
polycassine extracted from a kind of plants, Indocalamus, in vitro
Yan Jiang*; C. Y. Chen; Y. Xiao; S. Coo; L.J. Pei; H. Zhang; Y.M. Shao, PR
China
NOTES

CONFERENCE WORKBOOK

189